MBAI
Check-Cap Ltd
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
Check-Cap Ltd
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
Check-Cap Ltd
2.02
−0.03 · −1.46%
post 2.02 0.00%
No changes.
No changes.
Same SIC code · 3
Same SEC industry code: GE HealthCare Technologies Inc., Butterfly Network, Inc. and Nano-X Imaging Ltd.; no measured co-movers for Check-Cap Ltd.
Same SIC code · 3
Same SEC industry code: GE HealthCare Technologies Inc., Butterfly Network, Inc. and Nano-X Imaging Ltd.; no measured co-movers for Check-Cap Ltd.
Annual filing, covered
20-F parsed · Apr 27 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
20-F parsed · Apr 27 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
−16.99%
shares held · 7 largest managers
| Manager | Value | % base | |
|---|---|---|---|
| Citadel | $47,160 | 47.56% | new |
| XTX Topco | $26,515 | 26.74% | new |
| UBS | $23,239 | 23.44% | −18.29% |
| JPMorgan Chase | $1,890 | 1.91% | 0.00% |
| Morgan Stanley | $196 | 0.20% | −0.64% |
| Manager | Value | % base | |
|---|---|---|---|
| Citadel | $47,160 | 47.56% | new |
| XTX Topco | $26,515 | 26.74% | new |
| UBS | $23,239 | 23.44% | −18.29% |
| JPMorgan Chase | $1,890 | 1.91% | 0.00% |
| Morgan Stanley | $196 | 0.20% | −0.64% |